Journals / Sakarya University Journal of Science / 2019 / Cilt: 23 Sayı: 6

Computational Interrogation of The Human Norovirus-Host Cell Interactions Facilitated by A-Type Antigen

Pages
1056–1065
Publication Date
2019-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This fluctuation leads an instability in capsid particle that may be an indication for virus uncoating mechanism during the cell penetration.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Norovirus infectivity, which causes norovirus-induced gastroenteritis, depends on the interaction between capsid protein VP1 of the virus and host cell HGBA receptors that tailor the cell membrane surface.
📊
Key Findings & Data:The interaction results in VP1-HGBA complex formation prior to infection.
💡
Conclusion & Impact:This fluctuation leads an instability in capsid particle that may be an indication for virus uncoating mechanism during the cell penetration.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Norovirus · therapeutic antibody · HBGA blockage

Abstract

Norovirus infectivity, which causes norovirus-induced gastroenteritis, depends on the interaction between capsid protein VP1 of the virus and host cell HGBA receptors that tailor the cell membrane surface. The interaction results in VP1-HGBA complex formation prior to infection. The details of this interaction have been provided by x-ray structures of HGBA-VP1 complexes, but the dynamic nature of this interaction is not fully uncovered. Therefore, the dynamics that drive the formation of VP1-HGBA complex, which is crucial for developing new therapeutic approaches to find a cure for gastroenteritis disease, need to be elucidated. Here, we computationally analyzed the wild type VP1 capsid protein in complex with A-type HGBA antigen to unravel interactions that are important for virus to enter inside the host cell during infection. We have found that the ligand binding causes a fluctuation in a distant loop which resides in the interface of capsid building blocks, VP proteins. This fluctuation leads an instability in capsid particle that may be an indication for virus uncoating mechanism during the cell penetration.

🔖

Cite This Article

KOCAK, A., YİLDİZ, M. (2019). Computational Interrogation of The Human Norovirus-Host Cell Interactions Facilitated by A-Type Antigen. Sakarya University Journal of Science, Cilt: 23 Sayı: 6, 1056–1065. https://ajindex.com/articles/941967

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. A. Z. Kapikian, R. G. Wyatt, R. Dolin, T. S. Thornhill, A. R. Kalica, and R. M. Chanock, "Visualization by Immune Electron-Microscopy of a 27-Nm Particle Associated with Acute Infectious Nonbacterial Gastroenteritis," Journal of Virology, vol. 10, pp. 1075-1081, 1972.
  2. K. L. Kotloff, J. P. Nataro, W. C. Blackwelder, D. Nasrin, T. H. Farag, S. Panchalingam, et al., "Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study," Lancet, vol. 382, pp. 209-22, Jul 20 2013.
  3. G. Belliot, B. A. Lopman, K. Ambert-Balay, and P. Pothier, "The burden of norovirus gastroenteritis: an important foodborne and healthcare-related infection," Clin Microbiol Infect, vol. 20, pp. 724-30, Aug 2014.
  4. A. Kambhampati, M. Koopmans, and B. A. Lopman, "Burden of norovirus in healthcare facilities and strategies for outbreak control," J Hosp Infect, vol. 89, pp. 296-301, Apr 2015.
  5. T. N. Hoa Tran, E. Trainor, T. Nakagomi, N. A. Cunliffe, and O. Nakagomi, "Molecular epidemiology of noroviruses associated with acute sporadic gastroenteritis in children: global distribution of genogroups, genotypes and GII.4 variants," J Clin Virol, vol. 56, pp. 185-93, Mar 2013.
  6. S. M. Karst, C. E. Wobus, I. G. Goodfellow, K. Y. Green, and H. W. Virgin, "Advances in norovirus biology," Cell Host Microbe, vol. 15, pp. 668-80, Jun 11 2014.
  7. J. Rocha-Pereira, J. Neyts, and D. Jochmans, "Norovirus: targets and tools in antiviral drug discovery," Biochem Pharmacol, vol. 91, pp. 1-11, Sep 1 2014. M. Tan and X. Jiang, "Vaccine against norovirus," Hum Vaccin Immunother, vol. 10, pp. 1449-56, 2014.
  8. N. Aliabadi, B. A. Lopman, U. D. Parashar, and A. J. Hall, "Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations," Expert Rev Vaccines, vol. 14, pp. 1241-53, 2015.
  9. E. Robilotti, S. Deresinski, and B. A. Pinsky, "Norovirus," Clin Microbiol Rev, vol. 28, pp. 134-64, Jan 2015.
  10. S. M. Karst, S. Zhu, and I. G. Goodfellow, "The molecular pathology of noroviruses," J Pathol, vol. 235, pp. 206-16, Jan 2015. P. A. White, "Evolution of norovirus," Clin Microbiol Infect, vol. 20, pp. 741-5, Aug 2014.
  11. M. M. Patel, A. J. Hall, J. Vinje, and U. D. Parashar, "Noroviruses: a comprehensive review," J Clin Virol, vol. 44, pp. 1-8, Jan 2009.
  12. S. Caddy, A. Breiman, J. le Pendu, and I. Goodfellow, "Genogroup IV and VI canine noroviruses interact with histo-bl